NasdaqCM - Delayed Quote • USD
BIO-key International, Inc. (BKYI)
At close: April 18 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -0.29 | -0.4 | -- | -- |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 1.83M | 3.15M | 10M | 19M |
| Low Estimate | 2.55M | 3.15M | 10M | 19M |
| High Estimate | 2.55M | 3.15M | 10M | 19M |
| Year Ago Sales | 1.37M | 1.76M | 7.02M | 10M |
| Sales Growth (year/est) | 33.00% | 79.20% | 42.50% | 90.00% |
Earnings History
| CURRENCY IN USD | 9/30/2022 | 12/31/2022 | 3/31/2023 | 6/30/2023 |
|---|---|---|---|---|
| EPS Est. | -0.16 | -0.27 | -0.27 | -0.23 |
| EPS Actual | -0.29 | -0.4 | -0.08 | -0.16 |
| Difference | -0.13 | -0.13 | 0.19 | 0.07 |
| Surprise % | -81.20% | -48.10% | 70.40% | 30.40% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | -0.2 | -0.17 | -0.87 | -0.46 |
| 30 Days Ago | -0.2 | -0.17 | -0.87 | -0.46 |
| 60 Days Ago | -0.2 | -0.17 | -0.87 | -0.46 |
| 90 Days Ago | -0.2 | -0.17 | -0.87 | -0.46 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2023) | Next Qtr. (Dec 2023) | Current Year (2023) | Next Year (2024) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | BKYI | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | -- | -- | -- | 0.80% |
| Next Qtr. | -- | -- | -- | 9.60% |
| Current Year | -- | -- | -- | 4.50% |
| Next Year | -- | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.09% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Related Tickers
NL NL Industries, Inc.
7.64
-1.29%
VRME VerifyMe, Inc.
1.5880
+0.51%
BCO The Brink's Company
86.29
+0.08%
BAER Bridger Aerospace Group Holdings, Inc.
5.07
+2.42%
MSA MSA Safety Incorporated
185.55
-0.19%
IVDA Iveda Solutions, Inc.
0.8441
+0.96%
MG Mistras Group, Inc.
8.94
-1.76%
NSSC Napco Security Technologies, Inc.
39.73
+1.85%
ALLE Allegion plc
124.84
-0.75%
SPCB SuperCom Ltd.
0.2400
-33.31%